The results of the present study confirmed that after YPFS treatment of AR mice and EGFR reduction, the expression of inflammatory factors in the OVA-induced AR group decreased, and rhinitis symptoms were alleviated, suggesting that EGFR reduction benefits AR treatment. This evidence concerns the gene EGFR and rhinitis.